Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global All Vaccine Market Report for Period 2018 till 2026

Single User: $2999
Multiple User: $3999
Enterprise User: $4999


Report Summary:

A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the bodys immune system to recognize the agent as a threat, destroy it, and keep a record of it so that the immune system can more easily recognize and destroy any of these microorganisms that it later encounters. Vaccines can be prophylactic (example: to prevent or ameliorate the effects of a future infection by any natural or wild pathogen), or therapeutic (e.g., vaccines against cancer are being investigated).

Scope of the Report:
This report focuses on the All Vaccine in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
CNBG
ChengDa Bio
Changsheng Life
Zhifei
SINOVAC BIOTECH
NuoCheng Bio
Hualan Bio
Kangtai
SANOFI PASTEUR S.A.
Novartis
GSK

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, tetanus
Pneumococcal
Other

Market Segment by Applications, can be divided into
For Adult
For Child

There are 15 Chapters to deeply display the global All Vaccine market.

Chapter 1, to describe All Vaccine Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of All Vaccine, with sales, revenue, and price of All Vaccine, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of All Vaccine, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, All Vaccine market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe All Vaccine sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents / Index:

Table of Contents
1 Market Overview
1.1 All Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Varicella
1.2.2 Influenza
1.2.3 Polio
1.2.4 Hepatitis A
1.2.5 Rabies
1.2.6 BCG
1.2.7 Hepatitis B
1.2.8 Pertussis, Diphtheria, tetanus
1.2.9 Pneumococcal
1.2.10 Other
1.3 Market Analysis by Applications
1.3.1 For Adult
1.3.2 For Child
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CNBG
2.1.1 Business Overview
2.1.2 All Vaccine Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 CNBG All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 ChengDa Bio
2.2.1 Business Overview
2.2.2 All Vaccine Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 ChengDa Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Changsheng Life
2.3.1 Business Overview
2.3.2 All Vaccine Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Changsheng Life All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Zhifei
2.4.1 Business Overview
2.4.2 All Vaccine Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Zhifei All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 SINOVAC BIOTECH
2.5.1 Business Overview
2.5.2 All Vaccine Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 SINOVAC BIOTECH All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 NuoCheng Bio
2.6.1 Business Overview
2.6.2 All Vaccine Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 NuoCheng Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Hualan Bio
2.7.1 Business Overview
2.7.2 All Vaccine Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Hualan Bio All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Kangtai
2.8.1 Business Overview
2.8.2 All Vaccine Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Kangtai All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 SANOFI PASTEUR S.A.
2.9.1 Business Overview
2.9.2 All Vaccine Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 SANOFI PASTEUR S.A. All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Novartis
2.10.1 Business Overview
2.10.2 All Vaccine Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 Novartis All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 GSK
2.11.1 Business Overview
2.11.2 All Vaccine Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 GSK All Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global All Vaccine Market Competition, by Manufacturer
3.1 Global All Vaccine Sales and Market Share by Manufacturer (2016-2017)
3.2 Global All Vaccine Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global All Vaccine Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 All Vaccine Manufacturer Market Share in 2017
3.4.2 Top 5 All Vaccine Manufacturer Market Share in 2017
3.5 Market Competition Trend
4 Global All Vaccine Market Analysis by Regions
4.1 Global All Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global All Vaccine Sales by Regions (2013-2018)
4.1.2 Global All Vaccine Revenue by Regions (2013-2018)
4.2 North America All Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe All Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific All Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.5 South America All Vaccine Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa All Vaccine Sales, Revenue and Growth Rate (2013-2018)
5 North America All Vaccine by Countries, Type, Application and Manufacturers
5.1 North America All Vaccine Sales, Revenue and Market Share by Countries
5.1.1 North America All Vaccine Sales by Countries (2013-2018)
5.1.2 North America All Vaccine Revenue by Countries (2013-2018)
5.1.3 United States All Vaccine Sales and Growth Rate (2013-2018)
5.1.4 Canada All Vaccine Sales and Growth Rate (2013-2018)
5.1.5 Mexico All Vaccine Sales and Growth Rate (2013-2018)
5.2 North America All Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
5.2.1 North America All Vaccine Sales by Manufacturers (2016-2017)
5.2.2 North America All Vaccine Revenue by Manufacturers (2016-2017)
5.3 North America All Vaccine Sales, Revenue and Market Share by Type (2013-2018)
5.3.1 North America All Vaccine Sales and Sales Share by Type (2013-2018)
5.3.2 North America All Vaccine Revenue and Revenue Share by Type (2013-2018)
5.4 North America All Vaccine Sales, Revenue and Market Share by Application (2013-2018)
5.4.1 North America All Vaccine Sales and Sales Share by Application (2013-2018)
5.4.2 North America All Vaccine Revenue and Revenue Share by Application (2013-2018)
6 Europe All Vaccine by Countries, Type, Application and Manufacturers
6.1 Europe All Vaccine Sales, Revenue and Market Share by Countries
6.1.1 Europe All Vaccine Sales by Countries (2013-2018)
6.1.2 Europe All Vaccine Revenue by Countries (2013-2018)
6.1.3 Germany All Vaccine Sales and Growth Rate (2013-2018)
6.1.4 UK All Vaccine Sales and Growth Rate (2013-2018)
6.1.5 France All Vaccine Sales and Growth Rate (2013-2018)
6.1.6 Russia All Vaccine Sales and Growth Rate (2013-2018)
6.1.7 Italy All Vaccine Sales and Growth Rate (2013-2018)
6.2 Europe All Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
6.2.1 Europe All Vaccine Sales by Manufacturers (2016-2017)
6.2.2 Europe All Vaccine Revenue by Manufacturers (2016-2017)
6.3 Europe All Vaccine Sales, Revenue and Market Share by Type (2013-2018)
6.3.1 Europe All Vaccine Sales and Sales Share by Type (2013-2018)
6.3.2 Europe All Vaccine Revenue and Revenue Share by Type (2013-2018)
6.4 Europe All Vaccine Sales, Revenue and Market Share by Application (2013-2018)
6.4.1 Europe All Vaccine Sales and Sales Share by Application (2013-2018)
6.4.2 Europe All Vaccine Revenue and Revenue Share by Application (2013-2018)
7 Asia-Pacific All Vaccine by Countries, Type, Application and Manufacturers
7.1 Asia-Pacific All Vaccine Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific All Vaccine Sales by Countries (2013-2018)
7.1.2 Asia-Pacific All Vaccine Revenue by Countries (2013-2018)
7.1.3 China All Vaccine Sales and Growth Rate (2013-2018)
7.1.4 Japan All Vaccine Sales and Growth Rate (2013-2018)
7.1.5 Korea All Vaccine Sales and Growth Rate (2013-2018)
7.1.6 India All Vaccine Sales and Growth Rate (2013-2018)
7.1.7 Southeast Asia All Vaccine Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific All Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
7.2.1 Asia-Pacific All Vaccine Sales by Manufacturers (2016-2017)
7.2.2 Asia-Pacific All Vaccine Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific All Vaccine Sales, Revenue and Market Share by Type (2013-2018)
7.3.1 Asia-Pacific All Vaccine Sales and Sales Share by Type (2013-2018)
7.3.2 Asia-Pacific All Vaccine Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific All Vaccine Sales, Revenue and Market Share by Application (2013-2018)
7.4.1 Asia-Pacific All Vaccine Sales and Sales Share by Application (2013-2018)
7.4.2 Asia-Pacific All Vaccine Revenue and Revenue Share by Application (2013-2018)
8 South America All Vaccine by Countries, Type, Application and Manufacturers
8.1 South America All Vaccine Sales, Revenue and Market Share by Countries
8.1.1 South America All Vaccine Sales by Countries (2013-2018)
8.1.2 South America All Vaccine Revenue by Countries (2013-2018)
8.1.3 Brazil All Vaccine Sales and Growth Rate (2013-2018)
8.1.4 Argentina All Vaccine Sales and Growth Rate (2013-2018)
8.1.5 Colombia All Vaccine Sales and Growth Rate (2013-2018)
8.2 South America All Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
8.2.1 South America All Vaccine Sales by Manufacturers (2016-2017)
8.2.2 South America All Vaccine Revenue by Manufacturers (2016-2017)
8.3 South America All Vaccine Sales, Revenue and Market Share by Type (2013-2018)
8.3.1 South America All Vaccine Sales and Sales Share by Type (2013-2018)
8.3.2 South America All Vaccine Revenue and Revenue Share by Type (2013-2018)
8.4 South America All Vaccine Sales, Revenue and Market Share by Application (2013-2018)
8.4.1 South America All Vaccine Sales and Sales Share by Application (2013-2018)
8.4.2 South America All Vaccine Revenue and Revenue Share by Application (2013-2018)
9 Middle East and Africa All Vaccine by Countries, Type, Application and Manufacturers
9.1 Middle East and Africa All Vaccine Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa All Vaccine Sales by Countries (2013-2018)
9.1.2 Middle East and Africa All Vaccine Revenue by Countries (2013-2018)
9.1.3 Saudi Arabia All Vaccine Sales and Growth Rate (2013-2018)
9.1.4 UAE All Vaccine Sales and Growth Rate (2013-2018)
9.1.5 Egypt All Vaccine Sales and Growth Rate (2013-2018)
9.1.6 Nigeria All Vaccine Sales and Growth Rate (2013-2018)
9.1.7 South Africa All Vaccine Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa All Vaccine Sales and Revenue (Value) by Manufacturers (2016-2017)
9.2.1 Middle East and Africa All Vaccine Sales by Manufacturers (2016-2017)
9.2.2 Middle East and Africa All Vaccine Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa All Vaccine Sales, Revenue and Market Share by Type (2013-2018)
9.3.1 Middle East and Africa All Vaccine Sales and Sales Share by Type (2013-2018)
9.3.1 Middle East and Africa All Vaccine Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa All Vaccine Sales, Revenue and Market Share by Application (2013-2018)
9.4.1 Middle East and Africa All Vaccine Sales and Sales Share by Application (2013-2018)
9.4.2 Middle East and Africa All Vaccine Revenue and Revenue Share by Application (2013-2018)
10 Global All Vaccine Market Segment by Type
10.1 Global All Vaccine Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global All Vaccine Sales and Market Share by Type (2013-2018)
10.1.2 Global All Vaccine Revenue and Market Share by Type (2013-2018)
10.2 Varicella Sales Growth and Price
10.2.1 Global Varicella Sales Growth (2013-2018)
10.2.2 Global Varicella Price (2013-2018)
10.3 Influenza Sales Growth and Price
10.3.1 Global Influenza Sales Growth (2013-2018)
10.3.2 Global Influenza Price (2013-2018)
10.4 Polio Sales Growth and Price
10.4.1 Global Polio Sales Growth (2013-2018)
10.4.2 Global Polio Price (2013-2018)
10.5 Hepatitis A Sales Growth and Price
10.5.1 Global Hepatitis A Sales Growth (2013-2018)
10.5.2 Global Hepatitis A Price (2013-2018)
10.6 Rabies Sales Growth and Price
10.6.1 Global Rabies Sales Growth (2013-2018)
10.6.2 Global Rabies Price (2013-2018)
10.7 BCG Sales Growth and Price
10.7.1 Global BCG Sales Growth (2013-2018)
10.7.2 Global BCG Price (2013-2018)
10.8 Hepatitis B Sales Growth and Price
10.8.1 Global Hepatitis B Sales Growth (2013-2018)
10.8.2 Global Hepatitis B Price (2013-2018)
10.9 Pertussis, Diphtheria, tetanus Sales Growth and Price
10.9.1 Global Pertussis, Diphtheria, tetanus Sales Growth (2013-2018)
10.9.2 Global Pertussis, Diphtheria, tetanus Price (2013-2018)
10.10 Pneumococcal Sales Growth and Price
10.10.1 Global Pneumococcal Sales Growth (2013-2018)
10.10.2 Global Pneumococcal Price (2013-2018)
10.11 Other Sales Growth and Price
10.11.1 Global Other Sales Growth (2013-2018)
10.11.2 Global Other Price (2013-2018)
11 Global All Vaccine Market Segment by Application
11.1 Global All Vaccine Sales Market Share by Application (2013-2018)
11.2 For Adult Sales Growth (2013-2018)
11.3 For Child Sales Growth (2013-2018)
12 All Vaccine Market Forecast (2018-2023)
12.1 Global All Vaccine Sales, Revenue and Growth Rate (2018-2023)
12.2 All Vaccine Market Forecast by Regions (2018-2023)
12.2.1 North America All Vaccine Market Forecast (2018-2023)
12.2.2 Europe All Vaccine Market Forecast (2018-2023)
12.2.3 Asia-Pacific All Vaccine Market Forecast (2018-2023)
12.2.4 South America All Vaccine Market Forecast (2018-2023)
12.2.5 Middle East and Africa All Vaccine Market Forecast (2018-2023)
12.3 All Vaccine Market Forecast by Type (2018-2023)
12.3.1 Global All Vaccine Sales Forecast by Type (2018-2023)
12.3.2 Global All Vaccine Market Share Forecast by Type (2018-2023)
12.4 All Vaccine Market Forecast by Application (2018-2023)
12.4.1 Global All Vaccine Sales Forecast by Application (2018-2023)
12.4.2 Global All Vaccine Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source

Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 39974

Category: 16

Published date: 2018-05-23 07:41:54

Number of Pages: 105

Publisher Name: GIR

Over all Rating: 91 % (Average of Ratings provided by clients)